Heartstitch, Inc.

Heartstitch, Inc.
About Us
Follow us:
Share:
Subscribe:

About Us

About HeartStitch: HeartStitch®, Inc. was founded by Prof. Anthony Nobles with the intent of leveraging its technologies in the structural heart marketplace. HeartStitch® is focused on the innovative suture-based systems for remotely providing suture repair of structural heart defects and other vascular structures. HeartStitch® manufactures and markets the NobleStitch™ EL under and exclusive license from Nobles Medical Technologies II, Inc. NobleStitch™ EL is FDA cleared for vascular suturing in the United States and CE Marked for cardio-vascular suturing and PFO closure in the European Union. HeartStitch® is a registered trademark of HeartStitch®, Inc. For more on HeartStitch® visit www.HeartStitch.com

Pick a time period -

Tags ( Active)

All Regulatory Non-Regulatory

HeartStitch ® Launches German Sales of NobleStitch™ EL

Mon, May 02, 2016 13:02 CET

Expansion Marked By First Five PFO ClosuresFrankfurt, Germany – May 2, 2016 – Prof. Dr. Horst Sievert of the Cardiovascular Center, Frankfurt, successfully completed five PFO closures using the NobleStitch™ EL—marking the official sales release of the NobleStitch™ device in Germany. Dr. Michael Mullen, Cardiologist St. Bartholomew’s Hospital, London, and member of the HeartStitch® clinical advisory board, and Prof. Anthony Nobles, CEO of HeartStitch®—proctored Prof. Sievert and his team at the CVC Heart Center in Frankfurt on the NobleStitch™ EL PFO closure system. This followed

There are no items matching the current filter

There are no more items matching the current filter

Back to top

Share

About Us

HeartStitch ® Launches German Sales of NobleStitch™ EL